SAFE - First implantations of the Sycamore device in Switzerland
12 Juin 2024 - 6:00PM
SAFE - First implantations of the Sycamore device in Switzerland
First implantations of the Sycamore
device in Switzerland
Fleurieux-sur-l’Arbresle -
France – June 12, 2024 at 6 p.m. Safe SA,
announces the first implantations of Sycamore devices by Professor
Maestretti, at the cantonal hospital of Friborg in Switzerland. The
Sycamore implant is a unique implant that allows minimally invasive
operations to treat vertebral compression fractures, improve
mobility, restore the height of vertebral bodies and reduce back
pain (pedicle anchored kyphoplasty). This cutting-edge implant,
thanks to percutaneous surgery, offers an innovative solution to
the treatment of spinal fractures.
Professor Maestretti, an early adopter of Safe
Orthopedics' off-the-shelf technologies, adds: “We are happy to
benefit from Sycamore technology at the hospital. This minimally
invasive percutaneous innovation integrates perfectly with the
technologies already available, making it possible to broaden the
spectrum of indications for complex cases of vertebral metastases
and osteoporotic fractures. »
Nicolas PAPILLON, Deputy Managing Director of
Safe Orthopedics: “The Sycamore implant provides a unique solution
to surgeons for the treatment of certain types of spinal fractures.
This technology is a real asset that we have supported through
rigorous and extensive clinical monitoring since its launch. We are
particularly confident in the deployment of this solution which
more than ever confirms our pioneering position in ready-to-use
devices for the treatment of spinal pathologies and more
particularly fractures. We will also be placing a particular focus
on the Sycamore implant during the SFCR (French Society of Spine
Surgery) Congress which is taking place this week, from June 13 to
15, and where Safe Orthopedics is an exhibitor.”
About Safe GroupSafe Group is a
French medical technology group that brings together Safe
Orthopaedics, a pioneer in ready-to-use technologies for spine
pathologies, and Safe Medical (formerly LCI Medical), a medical
device subcontractor for orthopedic surgeries. The group employs
approximately 100 people.Safe Orthopaedics develops and
manufactures kits combining sterile implants and ready-to-use
instruments, available at any time to the surgeon. These
technologies are part of a minimally invasive approach aimed at
reducing the risks of contamination and infection, in the interest
of the patient and with a positive impact on hospitalization times
and costs. Protected by 15 patent families, SteriSpineTM kits are
CE marked and FDA approved. Safe Orthopaedics has subsidiaries in
the United Kingdom, Germany, the United States.For more
information: www.safeorthopaedics.com
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation center
and two production sites in France and in Tunisia, offering
numerous industrial services: industrialization, machining,
finishing and sterile packaging.For more information:
www.safemedical.fr
ContactsSAFE
GROUP AELYON
ADVISORSinvestors@safeorthopaedics.com safe@aelyonadvisors.fr
Safe Orthopaedics (LSE:0RAA)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Safe Orthopaedics (LSE:0RAA)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024